HOME >> MEDICINE >> NEWS
Artificial liver moves toward commercialization

Emergency device could save lives

SAN FRANCISCO -- In cases of severe liver failure, often the only effective alternative to keep a patient alive is a liver transplant. Due to a severe shortage of donor organs, many patients die waiting for suitable organs. An artificial liver that provides temporary support of a person's liver function can serve as a bridge to transplant or as a short-term treatment. Prototype devices, which filter blood toxins that build up as a result of liver damage, have been used in limited clinical trials to support patients. Advances in the development of this device, which could save many lives in the future, will be highlighted at the 219th national meeting of the American Chemical Society, the world's largest scientific society.

  • Upgraded device awaits human trials: The University of Minnesota bioartificial liver is among the earliest prototype devices still under development. To make it function longer than other models, researchers are using freshly isolated pig liver cells -- believed to work better than frozen liver cells -- as the substitute chemical-processing unit for the patient's liver. The first human clinical trials of this prototype device are scheduled to begin soon, pending U. S. Food and Drug Administration approval, among several patients with severe liver failure. (D. N. Adams, University of Minnesota, Minneapolis, Minn.; BIOT 81; Monday, March 27, 4:25 p.m.; Moscone Convention Center, Room 300, Esplanade Level. See page 68 in the final program.)

  • Improving device performance: Artificial livers currently being tested employ straight-line hollow fiber bioreactors to house the chemical-processing cells that substitute for the human liver. Such devices are subject to clogging and transport difficulties, resulting in poor transport of nu
    '"/>


Contact: charmayne Marsh
y_marsh@acs.org
202-872-4445
American Chemical Society
26-Mar-2000


Page: 1 2

Related medicine news :

1. Artificial liver trials show progress, as transplant candidates wait
2. Artificial organs
3. New Type Of Artificial Surfactant Shows Promise In Treating Lung Disease
4. Trial Begins For First Artificial Liver Device Using Human Cells
5. Research offers hope of new treatments for liver damage
6. Success of liver transplantation may be most influenced by three risk factors
7. Alcohol relapse adversely affects 10-year liver transplant survival
8. Donor age has no affect on long-term liver transplant survival
9. NHS stop-smoking services are insufficient to deliver national smoking targets
10. New ways to design safer & more effective topical (transdermal) drug delivery announced in the PNAS
11. Component of green tea protects injured livers in mice

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Artificial liver moves toward commercialization

(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... Curly Hair ... 14, the largest beauty event in the US, featuring products from all over the ... Keeper™ Collection. The Collection is a line of hair styling products focused entirely on ...
(Date:6/29/2015)... Petersburg, FL (PRWEB) , ... June 30, 2015 , ... ... a special 50% Off offer. The oil, ideal for natural skincare and even ... natural and easy way is something most people desire, and Oil Pulling can accomplish ...
(Date:6/29/2015)... ... June 30, 2015 , ... The United States Equestrian Federation (USEF) ... it becomes the Official Physical and Occupational Therapists of the U.S. Eventing Team. ... Event presented by Land Rover. , “The USEF is pleased to welcome the ...
(Date:6/29/2015)... ... June 30, 2015 , ... The ... for Neuro Musculoskeletal Thermography and Sympathetic Skin Response Studies.* , The new peer-reviewed ... published in 2006, are intended to aid physicians and thermal technologists in the ...
(Date:6/29/2015)... ... June 29, 2015 , ... ... to educate readers and potential patients about a variety of plastic surgery and ... dentistry and more. , It has been the main focus of Cosmetic Town ...
Breaking Medicine News(10 mins):Health News:Curly Hair Solutions™ Showcases Entire Curl Keeper™ Collection at Cosmoprof Las Vegas July 12 - 14 2Health News:New Product: Transform Wellness and Oral Health With This Ancient Ayurvedic Secret and Organic Product from Sublime Beauty NATURALS® 2Health News:KORT Physical Therapy Announces Partnership with The United States Equestrian Federation 2Health News:American Academy of Thermology Publishes Revised 2015 Guidelines for Neuro-Musculoskeletal Thermography and Sympathetic Skin Response Studies 2Health News:American Academy of Thermology Publishes Revised 2015 Guidelines for Neuro-Musculoskeletal Thermography and Sympathetic Skin Response Studies 3Health News:Board of Advisors Now Coming to Cosmetic Town 2
(Date:6/29/2015)... , June 30, 2015 , ... Corning and Gerresheimer enter into a 10-year-supply ... amount to EUR 196m debt-free Corning and ... for the pharmaceutical glass packaging market Gerresheimer,s outlook ... reflect the future disposal of the tubing business , ...
(Date:6/29/2015)... 29, 2015 EnteroMedics Inc. (NASDAQ: ETRM ... neuroblocking technology to treat obesity, metabolic diseases, and other ... underwritten public offering of units. Each unit will consist ... to purchase common stock and Series B warrants to ... the offering would result in them beneficially owning more ...
(Date:6/29/2015)...  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ) announced ... 1000 Index, effective June 26, 2015. The Russell 1000 ... the U.S. equity universe. It is a subset of ... the largest securities based on a combination of their ... are pleased to be added to this important index, ...
Breaking Medicine Technology:Gerresheimer Will Sell Tubing Operations to Corning - Both Will Form a Joint Venture to Accelerate Innovations for Pharmaceutical Glass Packaging Market 2Gerresheimer Will Sell Tubing Operations to Corning - Both Will Form a Joint Venture to Accelerate Innovations for Pharmaceutical Glass Packaging Market 3EnteroMedics Inc. Announces Proposed Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Proposed Public Offering of Common Stock and Warrants 3ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 2ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 3
Cached News: